Orpha bearish - sellAll moving averages bearish.
RSI close to 30, but no buyers picking it up
MACD bearish
Broke last support on fibonacci.
Strong sell.
0%
0%
0%
0%
0%
About ORPHAZYME A/S
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Anders Fink Vadsholt
Website
orphazyme.com
Headquarters
Copenhagen
Employees
1
Founded
2009
ISIN
DK0060910917
Orphazyme A/S is a biopharmaceutical company, which engages in the development of treatment for patients living with life-threatening and debilitating rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Morkeberg Hinsby, Marja Jaattela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
